Korro Bio, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2017 | $-14.6M | $-16.5M | $1.9M | $91.0K |
| FY2018 | $-17.0M | $-17.5M | $436.0K | $455.0K |
| FY2019 | $34.2M | $33.2M | $1.1M | $3.6M |
| FY2020 | $-45.2M | $-51.9M | $6.7M | $10.0M |
| FY2021 | $-76.1M | $-79.0M | $2.9M | $21.8M |
| FY2022 | $-53.6M | $-58.8M | $5.1M | $19.8M |
| FY2023 | $-67.3M | $-75.1M | $7.8M | — |
| FY2024 | $-60.1M | $-78.0M | $17.9M | — |
| FY2025 | $-78.6M | $-79.1M | $518.0K | — |